Europe ADME Toxicology Testing Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$3,212.8

Forecast, 2030 (US$M)

$6,438.5

CAGR, 2024 - 2030

10.4%

Report Coverage

Europe

Europe adme toxicology testing market, 2018-2030 (US$M)

Related Markets

Global ADME Toxicology Testing Industry

North America ADME Toxicology Testing Market Outlook

Asia Pacific ADME Toxicology Testing Market Outlook

Latin America ADME Toxicology Testing Market Outlook

MEA ADME Toxicology Testing Market Outlook

Europe adme toxicology testing market highlights

The Europe adme toxicology testing market generated a revenue of USD 3,212.8 million in 2023.
The market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
In terms of segment, cell culture tech was the largest revenue generating technology in 2023.
Cell Culture Tech is the most lucrative technology segment registering the fastest growth during the forecast period.

Europe data book summary

Market revenue in 2023	USD 3,212.8 million
Market revenue in 2030	USD 6,438.5 million
Growth rate	10.4% (CAGR from 2023 to 2030)
Largest segment	Cell culture tech
Fastest growing segment	Cell Culture Tech
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Cell Culture Tech
Key market players worldwide	Thermo Fisher Scientific Inc, Promega, Agilent Technologies Inc, Curia, Dassault Systemes SE, Beckman Coulter, Catalent Inc, Charles River Laboratories International Inc, Labcorp Drug Development, Eurofins Scientific SE, GE HealthCare Technologies Inc Common Stock, Miltenyi Biotec, IQVIA Holdings Inc

Other key industry trends

In terms of revenue, Europe region accounted for 33.0% of the global adme toxicology testing market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 2,831.6 million by 2030.

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

ADME Toxicology Testing Market Scope

Adme toxicology testing market segmentation & scope

Technology

Cell Culture Tech

High Throughput Tech

Molecular Imaging

OMICS Tech

Application

Systemic Toxicity

Renal Toxicity

Hepatotoxicity

Neurotoxicity

Others

Method

Cellular Assay

Biochemical Assay

In Silica

Ex-vivo

End Use

Pharmaceutical & Biopharmaceutical Manufacturers

Contract Research Organizations (CROs)

Others

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Germany

Japan

China

Brazil

South Africa

ADME Toxicology Testing Market Companies

Name	Profile	# Employees	HQ	Website

Europe adme toxicology testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to adme toxicology testing market will help companies and investors design strategic landscapes.

Cell culture tech was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe adme toxicology testing market based on cell culture tech covering the revenue growth of each sub-segment from 2018 to 2030.

This is majorly due to support from government and non-government organizations towards R&D and development of novel therapeutics. Major European countries considered within the marketspace include UK, and Germany.

Moreover, rise in focus for Optimization of ADME profiles of bio-therapeutics further propels the market growth as bio-therapeutics are in high demand within the region. For instance, demand for therapeutic proteins or bio-therapeutics to treat autoimmune and other inflammatory conditions (e.g., osteoarthritis, sepsis, and chronic viral infections) has increased within the European countries.

Reasons to subscribe to Europe adme toxicology testing market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe adme toxicology testing market databook

Our clientele includes a mix of adme toxicology testing market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe adme toxicology testing market, including forecasts for subscribers. This continent databook contains high-level insights into Europe adme toxicology testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list